Use of chymase inhibitors for the prevention and/or treatment of arterio-venous graft failure

Abstract

Disclosed is a method of treating A-V graft failure in a subject in need of such treatment, said method comprising administering to said subject an effective amount of an agent that inhibits the production, release or neo-intima generating effects of chymase, wherein said effective amount of said agent is an amount effective to treat said A-V graft failure.

Dependencies are inferred from the claim text.